Physician profile
William P Dutton
NPI 1861472888
$582.64
in general payments reported to CMS, 2019-2025
11 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $70.26 · 2021: $146 · 2022: $50.89 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leica Microsystems INC. | $135.00 | 2025 | |
| Smith+Nephew, INC. | $104.80 | 2019-2021 | |
| Organogenesis INC. | $99.93 | 2019-2021 | |
| Hartmann USA, INC. | $53.83 | 2020-2021 | |
| Abbvie INC. | $36.63 | 2021-2022 | |
| Kci USA, INC. | $32.36 | 2020-2021 | |
| Aroa Biosurgery Incorporated | $31.59 | 2022 | |
| Osiris Therapeutics INC. | $28.81 | 2019 | |
| Mckesson Patient Care Solutions INC. | $25.69 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $19.62 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $14.38 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.